Clinical Trials Directory

Trials / Unknown

UnknownNCT00905008

Long-Term Safety of Drug Eluting Stents in the "Real World" (FReIburger STent Registry)

Long-Term Safety and Efficacy of Drug Eluting Stents in "Real World" - Results From the FReIburger STent Registry

Status
Unknown
Phase
Study type
Observational
Enrollment
1,502 (actual)
Sponsor
University Hospital Freiburg · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The FReIburger STent Registry (FRIST) is designed to determine the long term safety and efficacy of Drug Eluting Stents (DES) in a "real-world" patient population requiring stent implantation. FRIST included patients treated with DES and bare-metal stents (BMS) in the University Hospital of Freiburg, Germany, according to a non-restrictive inclusion criterion, in which virtually all consecutive patient subsets were considered eligible.

Conditions

Interventions

TypeNameDescription
PROCEDUREtransluminal percutaneous coronary interventionAll interventions were done according to current practice guidelines. The operator was responsible for the decision to choose a specific treatment strategy. Angiographic success was defined as residual stenosis \<30% by visual analysis in the presence of TIMI 3 flow grade. The patients were prescribed aspirin plus clopidogrel 75 mg per day, after a loading dose of 300 mg or 600 mg, before or during the index coronary intervention. After procedure, all patients were advised to maintain lifelong use of aspirin. The use of clopidogrel (75 mg per day) was always adapted according to guideline recommendations. Heparin was infused throughout the procedure to maintain an activated clotting time of at least 250 sec. The administration of platelet glycoprotein IIb/IIIa receptor blocker was encouraged, unless in existing contraindications.
DEVICEDrug-Eluting and Bare-Metal stentsSirolimus-eluting stents (Cypher®), Paclitaxel-eluting stents (Taxus®) Zotarolimus-eluting stents (Endeavor®) and uncoated (bare-metal) stents

Timeline

Start date
2006-10-01
Primary completion
2009-05-01
First posted
2009-05-20
Last updated
2009-05-20

Source: ClinicalTrials.gov record NCT00905008. Inclusion in this directory is not an endorsement.